ABOUT BIORASI
Biorasi is the Go-To CRO for global clinical trials! For over 20 years, we have been trusted by small to midsized biopharma companies to provide customized solutions for today’s clinical research challenges. Biorasi optimizes clinical studies for multiple therapeutic areas, reaching successful results through reliable, flexible, and accessible solutions provided by our #OneTeam of industry experts.
BLOGS
-
The convergence of recent technological advancements and Diversity Action Plans holds great promise for creating more inclusive clinical trials. Dr. Anosheh Afghahi explains why embracing diversity is important to clinical research.
-
Learn about the barriers and challenges involved in adherence to topical treatments in dermatology practice, as well as the tools and techniques to keep patients on track.
-
Find out how today’s FDA-approved obesity medications are primed to become tomorrow’s novel treatments across multidimensional states of disease — from diabetes to heart failure.
-
For APAC companies, it's important to identify the differences in care standards, formulate strategies for compliance, and develop solutions to bridge the regulatory gap and realize FDA approval.
-
Employee turnover, even during complex clinical trials, should never be the breaking point of a project. Avoid these instances and keep studies on track by developing proactive employee retention strategies.
-
What was once science fiction has moved up to second-line therapy. Read this author's take on navigating the trajectory of how CAR T-Cell Therapy will be used for diffuse large B-cell lymphoma.
CONTACT INFORMATION
Biorasi
18851 NE 29th Ave. Suite 800
Miami, FL 33180
UNITED STATES
Phone: +1 786-396-1273
Contact: Aimee Fernandes
WHITE PAPERS & CASE STUDIES
-
Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
-
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Assess the feasibility of India as a potential venue for HCC trials as well as its epidemiology, historical perceptions, and untapped potential for international clinical research opportunities.
-
Chronic kidney disease has become inextricably linked with cardiovascular conditions, a discovery that has yielded synergistic diagnosis and intervention methods. Dr. Jamie Dwyer explores the connection between these two diseases, which has brought about a sort of renaissance for nephrology research.
-
One of the tenets of clinical research is that findings often result in more questions than answers. For Huntington’s disease, the journey toward understanding and treatment continues to be a methodical one. Dr. Ole Isacson highlights two pathways to ongoing research for this rare disease.
-
While there are socioeconomic factors contributing to the reasons behind the lack of diversity, the exclusion of minority populations in clinical trials can be a scientifically flawed misstep. By focusing on a single demographic, clinical research findings become limited, and by ignoring other representative populations, "unexpected" side effects may be more commonplace while treatment success levels will vary.
-
Hematologist Dr. Robert S. Negrin takes a deep dive into identifying and understanding the central differentiators in cell therapy clinical trials.
-
Alzheimer’s Disease currently afflicts close to 50 million people worldwide, highlighting the importance of clinical trials for this condition. Alzheimer’s studies are unique in that they require an additional participant to assess the patient’s mental and physical health during the trial. But what are the characteristics of a viable study partner?
NEWS
-
Biorasi Joins Nova Southeastern University To Spur Healthcare Job Growth In South Florida9/8/2018
Biorasi, a leading full-service global contract research organization (CRO), is excited to announce two new certificate programs through Nova Southeastern University to provide targeted education and job skills for future healthcare workers in South Florida. The certificate programs are a joint effort between the two organizations to create a Clinical Research Associate (CRA) graduate certificate program through the university’s Dr. Pallavi Patel College of Health Care Sciences. This certificate program will help prepare students to enter the rapidly growing field of clinical research and provide them with the practical skills and knowledge to secure employment in a well-paying career in the sciences.